ARCH Venture Management, LLC
CHICAGO, IL · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.61B2026 Q3
Positions17
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.86.6%
What Changed This Quarter?
Top Holdings
KARD
Kardigan
13.8%
PBLS
Parabilis Medicines
12.8%
VIR
Vir Biotechnology
8.8%
SANA
Sana Biotechnology
8.3%
SPTX
Seaport Therapeutics
7.9%
RAPP
Rapport Therapeutics
7.8%
SRRK
Scholar Rock
7.0%
MAZE
Maze Therapeutics
6.9%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.